Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-04

FDA Approved: LEVORPHANOL TARTRATE — Supplemental Application (ACERTIS PHARMACEUTICALS, LLC)

View source ↗

Summary

FDA approved a supplemental application for levorphanol tartrate by Acetris Pharmaceuticals, LLC (ANDA211484).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levorphanol Tartrate (Levorphanol Tartrate)

Snippet

SUPPL AP for LEVORPHANOL TARTRATE (LEVORPHANOL TARTRATE)